Parallel Advisors’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Sell	96,254 -10,430	-10%	-$33K	﹤0.01%	1011
2025 Q4	$395K	Sell	106,684 -10,740	-9%	-$34.7K	0.01%	775
2025 Q3	$311K	Sell	117,424 -10,000	-8%	-$19.3K	0.01%	855
2025 Q2	$125K	Buy	127,424 +117,424	+1,174%	+$118K	﹤0.01%	1246
2025 Q1	$14.4K	Hold	10,000	–	–	﹤0.01%	2290
2024 Q4	$22K	Sell	10,000 -234,000	-96%	-$546K	﹤0.01%	2101
2024 Q3	$403K	Buy	244,000 +5,000	+2%	+$10.1K	0.01%	642
2024 Q2	$531K	Hold	239,000	–	–	0.01%	521
2024 Q1	$641K	Sell	239,000 -239,000	-50%	-$581K	0.02%	456
2023 Q4	$1.43M	Hold	478,000	–	–	0.04%	268
2023 Q3	$468K	Buy	+478,000	New	+$692K	0.02%	474
2023 Q2	–	Sell	-169	Closed	-$269	–	3416
2023 Q1	$269	Buy	+169	New	+$872	﹤0.01%	3245
2022 Q4	–	Sell	-53	Closed	–	–	3417
2022 Q3	$0	Buy	53 +18	+51%	+$124	﹤0.01%	3242
2022 Q2	$0	Buy	+35	New	+$198	﹤0.01%	3084
2022 Q1	–	Sell	-1,526	Closed	-$8K	–	3059
2021 Q4	$8K	Buy	1,526 +1,400	+1,111%	+$11.2K	﹤0.01%	2195
2021 Q3	$2K	Buy	126 +124	+6,200%	+$1.8K	﹤0.01%	2674
2021 Q2	$0	Hold	2	–	–	﹤0.01%	2967
2021 Q1	$0	Sell	2 -3	-60%	-$89	﹤0.01%	2826
2020 Q4	$0	Sell	5 -5	-50%	-$150	﹤0.01%	2602
2020 Q3	$0	Buy	+10	New	+$396	﹤0.01%	2591
2020 Q2	–	Sell	-17,710	Closed	-$558K	–	2515
2020 Q1	$558K	Hold	17,710	–	–	0.05%	225
2019 Q4	$1.06M	Buy	17,710 +10,000	+130%	+$450K	0.08%	176
2019 Q3	$283K	Buy	+7,710	New	+$305K	0.02%	388
2019 Q2	–	Sell	-2,000	Closed	-$80K	–	2347
2019 Q1	$80K	Buy	+2,000	New	+$89.7K	0.01%	685